Literature DB >> 17502457

Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection.

Angela J Peck1, Janet A Englund, Jane Kuypers, Katherine A Guthrie, Lawrence Corey, Rhoda Morrow, Robert C Hackman, Anne Cent, Michael Boeckh.   

Abstract

The incidence of respiratory virus infection after hematopoietic cell transplantation (HCT) has probably been underestimated with conventional testing methods in symptomatic patients. This prospective study assessed viral infection episodes by testing weekly respiratory samples collected from HCT recipients, with and without symptoms reported by questionnaire, for 100 days after HCT. Samples were tested by culture and direct fluorescent antibody testing for respiratory syncytial virus (RSV), parainfluenza virus (PIV), and influenza A and B, and by quantitative reverse transcription-polymerase chain reaction for RSV, PIV, influenza A and B, and metapneumovirus (MPV). Of 122 patients, 30 (25%) had 32 infection episodes caused by RSV (5), PIV (17), MPV (6), influenza (3), RSV, or influenza (1). PIV, with a cumulative incidence estimate of 17.9%, was the only virus for which asymptomatic infection was detected. Lower virus copy number in patients with no or one symptom compared with 2 or more symptoms was found for all viruses in all patients (P < .001), with PIV infection having a similar virus-specific comparison (P = .004). Subclinical infection with PIV may help explain why infection-control programs that emphasize symptoms are effective against RSV and influenza but often not against PIV.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17502457      PMCID: PMC1975849          DOI: 10.1182/blood-2006-12-060343

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  47 in total

1.  Pre-emptive ribavirin for 'RSV' in BMT.

Authors:  J DeVincenzo
Journal:  Bone Marrow Transplant       Date:  2000-07       Impact factor: 5.483

2.  Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants.

Authors:  M Boeckh; M M Berrey; R A Bowden; S W Crawford; J Balsley; L Corey
Journal:  J Infect Dis       Date:  2001-06-28       Impact factor: 5.226

3.  Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome.

Authors:  W G Nichols; L Corey; T Gooley; C Davis; M Boeckh
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

4.  Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population.

Authors:  K J Cortez; D D Erdman; T C Peret; V J Gill; R Childs; A J Barrett; J E Bennett
Journal:  J Infect Dis       Date:  2001-10-12       Impact factor: 5.226

5.  Preemptive treatment of pediatric bone marrow transplant patients with asymptomatic respiratory syncytial virus infection with aerosolized ribavirin.

Authors:  R H Adams
Journal:  Biol Blood Marrow Transplant       Date:  2001       Impact factor: 5.742

6.  Community respiratory virus infections in bone marrow transplant recipients: the M.D. Anderson Cancer Center experience.

Authors:  R E Champlin; E Whimbey
Journal:  Biol Blood Marrow Transplant       Date:  2001       Impact factor: 5.742

7.  Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience.

Authors:  W G Nichols; T Gooley; M Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2001       Impact factor: 5.742

8.  Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience.

Authors:  R A Bowden
Journal:  Am J Med       Date:  1997-03-17       Impact factor: 4.965

9.  Parainfluenza virus 3 infection after stem cell transplant: relevance to outcome of rapid diagnosis and ribavirin treatment.

Authors:  J Elizaga; E Olavarria; J Apperley; J Goldman; K Ward
Journal:  Clin Infect Dis       Date:  2001-01-25       Impact factor: 9.079

10.  A newly discovered human pneumovirus isolated from young children with respiratory tract disease.

Authors:  B G van den Hoogen; J C de Jong; J Groen; T Kuiken; R de Groot; R A Fouchier; A D Osterhaus
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

View more
  99 in total

Review 1.  The human metapneumovirus: a case series and review of the literature.

Authors:  S Shahda; W G Carlos; P J Kiel; B A Khan; C A Hage
Journal:  Transpl Infect Dis       Date:  2010-10-03       Impact factor: 2.228

2.  Human parainfluenza virus infection after hematopoietic stem cell transplantation: risk factors, management, mortality, and changes over time.

Authors:  Celalettin Ustun; Jiří Slabý; Ryan M Shanley; Jan Vydra; Angela R Smith; John E Wagner; Daniel J Weisdorf; Jo-Anne H Young
Journal:  Biol Blood Marrow Transplant       Date:  2012-04-21       Impact factor: 5.742

3.  Impact of corticosteroid treatment and antiviral therapy on clinical outcomes in hematopoietic cell transplant patients infected with influenza virus.

Authors:  Alexandre A Boudreault; Hu Xie; Wendy Leisenring; Janet Englund; Lawrence Corey; Michael Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2010-09-24       Impact factor: 5.742

Review 4.  Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Authors:  S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

Review 5.  Influenza prevention and treatment in transplant recipients and immunocompromised hosts.

Authors:  Michael G Ison
Journal:  Influenza Other Respir Viruses       Date:  2013-11       Impact factor: 4.380

Review 6.  How I treat influenza in patients with hematologic malignancies.

Authors:  Corey Casper; Janet Englund; Michael Boeckh
Journal:  Blood       Date:  2009-12-15       Impact factor: 22.113

Review 7.  Measles Resurgence and Drug Development.

Authors:  Richard K Plemper
Journal:  Curr Opin Virol       Date:  2020-04-01       Impact factor: 7.090

8.  Management of respiratory viral infections in hematopoietic cell transplant recipients.

Authors:  Dimpy P Shah; Shashank S Ghantoji; Victor E Mulanovich; Ella J Ariza-Heredia; Roy F Chemaly
Journal:  Am J Blood Res       Date:  2012-11-25

9.  Respiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCT.

Authors:  Angela P Campbell; Jason W Chien; Jane Kuypers; Janet A Englund; Anna Wald; Katherine A Guthrie; Lawrence Corey; Michael Boeckh
Journal:  J Infect Dis       Date:  2010-05-01       Impact factor: 5.226

Review 10.  The challenge of respiratory virus infections in hematopoietic cell transplant recipients.

Authors:  Michael Boeckh
Journal:  Br J Haematol       Date:  2008-09-10       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.